000 01719 a2200481 4500
005 20250515075519.0
264 0 _c20071218
008 200712s 0 0 eng d
022 _a1527-3350
024 7 _a10.1002/hep.21848
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLewis, James H
245 0 0 _aEfficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.
_h[electronic resource]
260 _bHepatology (Baltimore, Md.)
_cNov 2007
300 _a1453-63 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAlanine Transaminase
_xblood
650 0 4 _aAnticholesteremic Agents
_xadverse effects
650 0 4 _aCholesterol, HDL
_xblood
650 0 4 _aCholesterol, LDL
_xblood
650 0 4 _aChronic Disease
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHypercholesterolemia
_xblood
650 0 4 _aLiver
_xenzymology
650 0 4 _aLiver Diseases
_xcomplications
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPravastatin
_xadverse effects
650 0 4 _aTreatment Outcome
650 0 4 _aTriglycerides
_xblood
700 1 _aMortensen, Mary Ellen
700 1 _aZweig, Steven
700 1 _aFusco, Mary Jean
700 1 _aMedoff, Jeffrey R
700 1 _aBelder, Rene
773 0 _tHepatology (Baltimore, Md.)
_gvol. 46
_gno. 5
_gp. 1453-63
856 4 0 _uhttps://doi.org/10.1002/hep.21848
_zAvailable from publisher's website
999 _c17201699
_d17201699